Prof Maria Paola Costi talks to ecancer at the 4th EUTROC meeting in Liverpool, UK about new drug developments and the main issues surrounding the drug approval process for ovarian cancer. She highlights work being done on folate receptors and their role in ovarian cancer; in particular, a project discussed at the meeting on candidate drugs targeting this receptor and the difficulty of advancing these drugs to the clinical stages.
Drug approval process for ovarian cancer / Costi, Maria Paola. - ELETTRONICO. - 15-11-2012:(2012).
Drug approval process for ovarian cancer
COSTI, Maria Paola
2012
Abstract
Prof Maria Paola Costi talks to ecancer at the 4th EUTROC meeting in Liverpool, UK about new drug developments and the main issues surrounding the drug approval process for ovarian cancer. She highlights work being done on folate receptors and their role in ovarian cancer; in particular, a project discussed at the meeting on candidate drugs targeting this receptor and the difficulty of advancing these drugs to the clinical stages.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
